• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唑来膦酸克服恶性间皮瘤的化疗耐药性和免疫抑制。

Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma.

作者信息

Salaroglio Iris Chiara, Campia Ivana, Kopecka Joanna, Gazzano Elena, Orecchia Sara, Ghigo Dario, Riganti Chiara

机构信息

Department of Oncology, University of Torino, Italy.

S.C. Anatomia Patologica, Azienda Ospedaliera S.S. Antonio e Biagio, Alessandria, Italy.

出版信息

Oncotarget. 2015 Jan 20;6(2):1128-42. doi: 10.18632/oncotarget.2731.

DOI:10.18632/oncotarget.2731
PMID:25544757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4359222/
Abstract

The human malignant mesothelioma (HMM) is characterized by a chemoresistant and immunosuppressive phenotype. An effective strategy to restore chemosensitivity and immune reactivity against HMM is lacking. We investigated whether the use of zoledronic acid is an effective chemo-immunosensitizing strategy. We compared primary HMM samples with non-transformed mesothelial cells. HMM cells had higher rate of cholesterol and isoprenoid synthesis, constitutive activation of Ras/extracellular signal-regulated kinase1/2 (ERK1/2)/hypoxia inducible factor-1α (HIF-1α) pathway and up-regulation of the drug efflux transporter P-glycoprotein (Pgp). By decreasing the isoprenoid supply, zoledronic acid down-regulated the Ras/ERK1/2/HIF-1α/Pgp axis and chemosensitized the HMM cells to Pgp substrates. The HMM cells also produced higher amounts of kynurenine, decreased the proliferation of T-lymphocytes and expanded the number of T-regulatory (Treg) cells. Kynurenine synthesis was due to the transcription of the indoleamine 1,2 dioxygenase (IDO) enzyme, consequent to the activation of the signal transducer and activator of transcription-3 (STAT3). By reducing the activity of the Ras/ERK1/2/STAT3/IDO axis, zoledronic acid lowered the kyurenine synthesis and the expansion of Treg cells, and increased the proliferation of T-lymphocytes. Thanks to its ability to decrease Ras/ERK1/2 activity, which is responsible for both Pgp-mediated chemoresistance and IDO-mediated immunosuppression, zoledronic acid is an effective chemo-immunosensitizing agent in HMM cells.

摘要

人类恶性间皮瘤(HMM)具有化学抗性和免疫抑制表型。目前缺乏恢复对HMM化学敏感性和免疫反应性的有效策略。我们研究了使用唑来膦酸是否是一种有效的化学免疫致敏策略。我们将原发性HMM样本与未转化的间皮细胞进行了比较。HMM细胞具有更高的胆固醇和类异戊二烯合成率、Ras/细胞外信号调节激酶1/2(ERK1/2)/缺氧诱导因子-1α(HIF-1α)途径的组成性激活以及药物外排转运蛋白P-糖蛋白(Pgp)的上调。通过减少类异戊二烯供应,唑来膦酸下调了Ras/ERK1/2/HIF-1α/Pgp轴,并使HMM细胞对Pgp底物产生化学敏感性。HMM细胞还产生了更高量的犬尿氨酸,降低了T淋巴细胞的增殖,并增加了调节性T(Treg)细胞的数量。犬尿氨酸的合成是由于吲哚胺2,3-双加氧酶(IDO)的转录,这是信号转导和转录激活因子-3(STAT3)激活的结果。通过降低Ras/ERK1/2/STAT3/IDO轴的活性,唑来膦酸降低了犬尿氨酸的合成和Treg细胞的扩增,并增加了T淋巴细胞的增殖。由于唑来膦酸能够降低Ras/ERK1/2活性,而Ras/ERK1/2活性既导致Pgp介导的化学抗性又导致IDO介导的免疫抑制,因此唑来膦酸是HMM细胞中一种有效的化学免疫致敏剂。

相似文献

1
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma.唑来膦酸克服恶性间皮瘤的化疗耐药性和免疫抑制。
Oncotarget. 2015 Jan 20;6(2):1128-42. doi: 10.18632/oncotarget.2731.
2
Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells.唑来膦酸恢复多药耐药人癌细胞对阿霉素的化疗敏感性和免疫原性细胞死亡。
PLoS One. 2013 Apr 12;8(4):e60975. doi: 10.1371/journal.pone.0060975. Print 2013.
3
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors.唑来膦酸包裹的自组装纳米颗粒与阿霉素:一种同时克服乳腺肿瘤化疗耐药性和免疫耐药性的联合方法。
Oncotarget. 2016 Apr 12;7(15):20753-72. doi: 10.18632/oncotarget.8012.
4
Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells.包裹唑来膦酸的自组装纳米颗粒可逆转癌细胞的多药耐药性。
Oncotarget. 2015 Oct 13;6(31):31461-78. doi: 10.18632/oncotarget.5058.
5
Zoledronic acid produces antitumor effects on mesothelioma through apoptosis and S-phase arrest in p53-independent and Ras prenylation-independent manners.唑来膦酸通过非依赖 p53 途径和非依赖 Ras 异戊烯化途径诱导间皮瘤细胞凋亡和 S 期阻滞而产生抗肿瘤作用。
J Thorac Oncol. 2012 May;7(5):873-82. doi: 10.1097/JTO.0b013e31824c7d43.
6
Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma.缺氧促进人恶性间皮瘤获得侵袭表型。
BMC Cancer. 2018 Aug 15;18(1):819. doi: 10.1186/s12885-018-4720-z.
7
Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells.过氧化氢促进人恶性间皮瘤细胞的上皮-间质转化和干性。
Asian Pac J Cancer Prev. 2013;14(6):3625-30. doi: 10.7314/apjcp.2013.14.6.3625.
8
An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells.一种自分泌细胞因子/JAK/STAT信号通路诱导多药耐药人类癌细胞中的犬尿氨酸合成。
PLoS One. 2015 May 8;10(5):e0126159. doi: 10.1371/journal.pone.0126159. eCollection 2015.
9
Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1alpha.石棉通过缺氧诱导因子-1α(HIF-1α)在MM98间皮瘤细胞中诱导多柔比星耐药。
Eur Respir J. 2008 Aug;32(2):443-51. doi: 10.1183/09031936.00090407. Epub 2008 Apr 2.
10
Indoleamine 2, 3-dioxygenase Up-regulates Hypoxia-inducible Factor-1α Expression by Degrading L-tryptophan but Not Its Activity in Human Alloreactive T-cells.吲哚胺2,3-双加氧酶通过降解L-色氨酸上调人同种异体反应性T细胞中缺氧诱导因子-1α的表达,但不影响其活性。
Iran J Allergy Asthma Immunol. 2018 Feb;17(1):56-67.

引用本文的文献

1
Role of indoleamine 2, 3-dioxygenase 1 in immunosuppression of breast cancer.吲哚胺2,3-双加氧酶1在乳腺癌免疫抑制中的作用
Cancer Pathog Ther. 2023 Nov 7;2(4):246-255. doi: 10.1016/j.cpt.2023.11.001. eCollection 2024 Oct.
2
Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma.慢性炎症、氧化应激与代谢可塑性:共同驱动间皮瘤致瘤微环境的三要素。
Cells. 2023 Aug 11;12(16):2048. doi: 10.3390/cells12162048.
3
Overcoming drug resistance in glioblastoma: new options in sight?

本文引用的文献

1
BRCA2 and RAD51 promote double-strand break formation and cell death in response to gemcitabine.BRCA2和RAD51促进吉西他滨诱导的双链断裂形成和细胞死亡。
Mol Cancer Ther. 2014 Oct;13(10):2412-21. doi: 10.1158/1535-7163.MCT-13-0862. Epub 2014 Jul 22.
2
Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation.自分泌集落刺激因子-1受体(CSF-1R)信号通过激活AKT驱动间皮瘤化疗耐药。
Cell Death Dis. 2014 Apr 10;5(4):e1167. doi: 10.1038/cddis.2014.136.
3
Systemic treatment of malignant pleural mesothelioma: new agents in clinical trials raise hope of relevant improvements.
克服胶质母细胞瘤中的耐药性:新的选择在望?
Cancer Drug Resist. 2021 Jun 19;4(2):512-516. doi: 10.20517/cdr.2021.03. eCollection 2021.
4
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons.缺氧、内质网应激与化疗耐药:危险的联姻。
J Exp Clin Cancer Res. 2021 Jan 11;40(1):28. doi: 10.1186/s13046-020-01824-3.
5
Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance.缺氧决定肿瘤代谢重编程:对化疗耐药性的影响。
Cells. 2020 Dec 4;9(12):2598. doi: 10.3390/cells9122598.
6
Control of adipogenic commitment by a STAT3-VSTM2A axis.STAT3-VSTM2A 轴对脂肪生成起始的调控作用。
Am J Physiol Endocrinol Metab. 2021 Feb 1;320(2):E259-E269. doi: 10.1152/ajpendo.00314.2020. Epub 2020 Nov 16.
7
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review.唑来膦酸抑制破骨细胞和骨癌转移的各种途径:简要综述。
BMC Cancer. 2020 Nov 3;20(1):1059. doi: 10.1186/s12885-020-07568-9.
8
The MEK/ERK Network as a Therapeutic Target in Human Cancer.MEK/ERK 网络作为人类癌症的治疗靶点。
Mol Cancer Res. 2021 Mar;19(3):361-374. doi: 10.1158/1541-7786.MCR-20-0687. Epub 2020 Nov 2.
9
New horizons from novel therapies in malignant pleural mesothelioma.新型疗法为恶性胸膜间皮瘤带来新希望。
Adv Respir Med. 2020;88(4):343-351. doi: 10.5603/ARM.a2020.0103.
10
ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma.ABCA1/ABCB1 比值决定人骨肉瘤的化疗和免疫敏感性。
Cells. 2020 Mar 6;9(3):647. doi: 10.3390/cells9030647.
恶性胸膜间皮瘤的系统治疗:临床试验中的新药物带来相关改善的希望。
Curr Opin Oncol. 2014 Mar;26(2):171-81. doi: 10.1097/CCO.0000000000000053.
4
Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition.ω-3 脂肪酸通过下调胆固醇合成和改变去污剂抗性膜组成来增敏多药耐药结肠癌细胞。
Mol Cancer. 2013 Nov 13;12:137. doi: 10.1186/1476-4598-12-137.
5
DNA repair capacity in peripheral blood lymphocytes predicts efficacy of platinum-based chemotherapy in patients with gastric cancer.外周血淋巴细胞中的DNA修复能力可预测胃癌患者铂类化疗的疗效。
Asian Pac J Cancer Prev. 2013;14(9):5507-12. doi: 10.7314/apjcp.2013.14.9.5507.
6
Chemotherapy for malignant pleural mesothelioma: a review of current management and a look to the future.恶性胸膜间皮瘤的化疗:当前治疗方法综述与未来展望
Ann Cardiothorac Surg. 2012 Nov;1(4):508-15. doi: 10.3978/j.issn.2225-319X.2012.10.05.
7
Systematic review of trimodality therapy for patients with malignant pleural mesothelioma.系统评价恶性胸膜间皮瘤三联疗法的疗效。
Ann Cardiothorac Surg. 2012 Nov;1(4):428-37. doi: 10.3978/j.issn.2225-319X.2012.11.07.
8
Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells.唑来膦酸恢复多药耐药人癌细胞对阿霉素的化疗敏感性和免疫原性细胞死亡。
PLoS One. 2013 Apr 12;8(4):e60975. doi: 10.1371/journal.pone.0060975. Print 2013.
9
Zoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by increasing p53 expression levels.唑来膦酸通过增加 p53 表达水平与顺铂联合对间皮瘤产生抗肿瘤作用。
PLoS One. 2013;8(3):e60297. doi: 10.1371/journal.pone.0060297. Epub 2013 Mar 28.
10
Gene therapy for malignant mesothelioma: current prospects and challenges.恶性间皮瘤的基因治疗:现状与挑战。
Cancer Gene Ther. 2013 Mar;20(3):150-6. doi: 10.1038/cgt.2013.1. Epub 2013 Feb 8.